A lower repeat price can justify comparing services, but changing providers also changes who assesses and follows your treatment. Arrange the handover before relying on the next parcel.
Identify the service, prescriber and pharmacy
An online brand may involve a prescribing service and a separate dispensing pharmacy. Check who performs each role and verify the relevant registrations through official records. Ask which organisation handles clinical questions, dispensing errors and delivery problems. Knowing the names makes a later problem easier to route correctly.
Compare contact arrangements as well as the price. A message portal is useful only if you know who reads it, what type of advice it provides and when to use another service. Ask for the urgent-care instructions and the routine clinical-response arrangements before transferring.
Prepare a concise treatment summary
Include the medicine and formulation, reason for treatment, starting date, dose history, last actual dose and remaining supply. Add weight response, troublesome symptoms, any urgent assessments and other medicines. Provide the previous prescriber's contact details and relevant records through the new service's secure process.
Do not rely only on an order receipt: it shows a purchase, not necessarily what was taken or how it was tolerated. Be clear about gaps, dose changes and unresolved symptoms. Accurate information helps the new clinician make a continuation decision and reduces the chance of conflicting instructions.
Sources: NICE: Prescribing, reviewing and stopping tirzepatide; General Pharmaceutical Council and UK health organisations: How to keep safe when getting medicines or treatment online
Expect the new clinician to make a decision
A previous prescription does not oblige another provider to continue the same treatment or strength. The new service needs enough information to assess suitability and may request additional checks. Explain what prompted the move, including cost, access to advice or practical problems, without assuming that every issue is purely commercial.
If the new clinician proposes a different medicine or dose, ask for the rationale and a written plan. Changing pharmacies is not automatically the same as switching medicines. Keep the two decisions distinct so the reason for each change and the responsible prescriber remain clear.
Sources: General Pharmaceutical Council and UK health organisations: How to keep safe when getting medicines or treatment online; MHRA: GLP-1 medicines for weight loss and diabetes: what you need to know
Prevent overlapping instructions and supplies
Tell both services about the proposed handover and any active repeat arrangement. Confirm when the old service's responsibility ends and when the new service takes over. Check cancellation terms separately from the clinical plan; stopping a subscription is not a medical instruction to stop a medicine.
Do not order overlapping treatment while giving each provider an incomplete history. If two prescriptions or conflicting instructions arise, ask the clinicians to clarify before using them. Remaining stock should be accounted for, but avoiding waste must not lead to combining products or creating an unprescribed schedule.
Sources: General Pharmaceutical Council and UK health organisations: How to keep safe when getting medicines or treatment online; Eli Lilly / electronic medicines compendium: Mounjaro KwikPen: patient information leaflet; Novo Nordisk / electronic medicines compendium: Wegovy tablets: patient information leaflet; Eli Lilly / electronic medicines compendium: Foundayo: patient information leaflet
Finish with a plan for the next review
Confirm the next dose, review date, repeat-order timing and contact point for side effects. If supply might be interrupted, ask for missed-dose or restart advice for the exact medicine. Keep a copy of the final plan and update your usual healthcare team as appropriate so another consultation does not rely on an obsolete record.
After the first new supply arrives, compare its label with that plan. Raise differences before use rather than assuming a packaging change is harmless. A successful transfer leaves you with one clear prescribing arrangement, a verified supply and a reachable route to clinical support.
Sources: General Pharmaceutical Council and UK health organisations: How to keep safe when getting medicines or treatment online; NICE: Prescribing, reviewing and stopping tirzepatide
Questions, answered.
Must a new provider accept my existing dose?
No. Its prescriber must assess whether continuation is appropriate and may require records or a fresh review.
Does cancelling a subscription tell me when to stop treatment?
No. Subscription administration and treatment decisions are separate. Obtain the clinical plan before a supply gap develops.
Sources: General Pharmaceutical Council and UK health organisations: How to keep safe when getting medicines or treatment online; NICE: Prescribing, reviewing and stopping tirzepatide
Sources & further reading
Original sources for this guide. Source checks are not independent clinical review.
- How to keep safe when getting medicines or treatment onlineGeneral Pharmaceutical Council and UK health organisations · Accessed 19 November 2026
- Prescribing, reviewing and stopping tirzepatideNICE · Accessed 19 November 2026
- GLP-1 medicines for weight loss and diabetes: what you need to knowMHRA · Accessed 19 November 2026
- Mounjaro KwikPen: patient information leafletEli Lilly / electronic medicines compendium · Accessed 19 November 2026
- Wegovy tablets: patient information leafletNovo Nordisk / electronic medicines compendium · Accessed 19 November 2026
- Foundayo: patient information leafletEli Lilly / electronic medicines compendium · Accessed 19 November 2026
